|
Market Closed -
Nasdaq
06:00:00 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 13.33 USD | +0.15% |
|
+6.73% | +238.32% |
| 21/09 | Turn Therapeutics Inc.(NasdaqGM:TTRX) added to S&P TMI Index | CI |
| 10/09 | Turn Therapeutics Inc. Announces Appointment of Robert R. Redfield as Chief Scientific Officer | CI |
| Market Cap | 397M 353M 329M 300M 566M 38.17B 571M 3.98B 1.54B 19.51B 1.49B 1.46B 62.63B | P/E 2026 * |
-29x | P/E 2027 * | -29.6x |
|---|---|---|---|---|---|
| Enterprise Value | 397M 353M 329M 300M 566M 38.17B 571M 3.98B 1.54B 19.51B 1.49B 1.46B 62.63B | EV / Sales 2026 * |
1,588x | EV / Sales 2027 * | 159x |
| Free-Float |
45.25% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TTRX | Delayed | |
CBOE
| TTRX | Real-time |
| 1 day | +0.15% | ||
| 1 week | +6.73% | ||
| Current month | -7.37% | ||
| 1 month | +37.85% | ||
| 3 months | +87.22% | ||
| 6 months | +297.91% | ||
| Current year | +238.32% |
| 1 week | 12.17 |  | 14.63 |
| 1 month | 9.7 | | 16.45 |
| Current year | 3.01 | | 16.45 |
| 1 year | 2.57 | | 26.5 |
| 3 years | 2.57 | | 26.5 |
| 5 years | 2.57 | | 26.5 |
| 10 years | 2.57 | | 26.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CEO | Chief Executive Officer | 48 | 06/01/2015 |
Zuraiz Chaudhary
DFI | Director of Finance/CFO | 31 | 01/05/2025 |
Stephen Hahn
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bradley Burnam
CHM | Chairman | 48 | - |
| Director/Board Member | 46 | 01/10/2018 | |
Andrew Gengos
BRD | Director/Board Member | 61 | 01/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/5/26 | Don | Chief Executive Officer | -1,200,000 | 4.0285% | ||
| 2/4/26 | Don | Chief Executive Officer | 300,000 | 1.0188% | ||
| 2/4/26 | Don | Director | 300,000 | 1.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.15% | +6.73% | - | - | 397M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | -0.19% | +0.14% | +54.39% | +120.28% | 39.09B | |
| Weighted average by Cap. | +0.12% | -0.83% | +58.77% | +129.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 250K 222K 207K 189K 356K 24.03M 360K 2.51M 972K 12.29M 939K 918K 39.43M | 2.5M 2.22M 2.07M 1.89M 3.56M 240M 3.6M 25.09M 9.72M 123M 9.39M 9.18M 394M |
| Net income | -15.5M -13.77M -12.85M -11.72M -22.1M -1.49B -22.3M -156M -60.28M -762M -58.19M -56.93M -2.44B | -23M -20.44M -19.07M -17.38M -32.79M -2.21B -33.09M -231M -89.44M -1.13B -86.35M -84.48M -3.63B |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | USD 13.33 | +0.15% | 136,298 |
| 01/10/26 | USD 13.31 | -7.51% | 122,089 |
| 30/09/26 | USD 14.39 | +7.31% | 88,715 |
| 29/09/26 | USD 13.41 | +2.84% | 79,533 |
| 28/09/26 | USD 13.04 | +4.40% | 76,732 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.33USD
Average target price
25.00USD
Spread / Average Target
+87.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TTRX Stock
Select your edition
All financial news and data tailored to specific country editions
